GLIS2 and CCND1 expression levels in breast cancer patients.

Sadeghi M, Gholizadeh M, Safataj N, Tahmasebivand M, Mohajeri G, Lotfi H, Bostanabad SY, Safar B, Salehi M

Open source

DOI
10.3233/bd-220068
Published
2023
Container
Breast disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3233/bd-220068,
  title = {GLIS2 and CCND1 expression levels in breast cancer patients.},
  author = {Sadeghi M and Gholizadeh M and Safataj N and Tahmasebivand M and Mohajeri G and Lotfi H and Bostanabad SY and Safar B and Salehi M},
  year = {2023},
  journal = {Breast disease},
  doi = {10.3233/bd-220068},
  url = {https://doi.org/10.3233/bd-220068}
}

RIS

TY  - JOUR
TI  - GLIS2 and CCND1 expression levels in breast cancer patients.
AU  - Sadeghi M
AU  - Gholizadeh M
AU  - Safataj N
AU  - Tahmasebivand M
AU  - Mohajeri G
AU  - Lotfi H
AU  - Bostanabad SY
AU  - Safar B
AU  - Salehi M
PY  - 2023
JO  - Breast disease
DO  - 10.3233/bd-220068
UR  - https://doi.org/10.3233/bd-220068
ER  - 

APA

M, S., M, G., N, S., M, T., G, M., H, L., SY, B., B, S., & M, S. (2023). GLIS2 and CCND1 expression levels in breast cancer patients.. Breast disease. https://doi.org/10.3233/bd-220068

Source records